Alzheimer’s drug from Biogen wins US approval – Financial Times

US regulators have approved an Alzheimer’s drug from Biogen that split the scientific community, marking a significant moment for sufferers of the disease and their families.
Aducanumab is designed … [+2394 chars]

View The Article On: Financial Times

Powered By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top